Previous Close | 25.82 |
Open | 26.48 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's Range | 25.82 - 26.79 |
52 Week Range | 13.48 - 27.00 |
Volume | |
Avg. Volume | 18,988 |
Market Cap | 303.557M |
Beta (5Y Monthly) | 0.59 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -4.04 |
Earnings Date | May 07, 2024 - May 13, 2024 |
Forward Dividend & Yield | 2.16 (8.26%) |
Ex-Dividend Date | Apr 02, 2024 |
1y Target Est | N/A |
The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But on the bright side, you...
Kinnate Stockholders to Receive $2.5879 Per Share in Cash Plus Contingent Value RightEMERYVILLE, Calif., April 03, 2024 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA) (“XOMA” or the “Company”), a biotechnology royalty aggregator playing a distinctive role in helping biotech companies achieve their goal of improving human health, today announced the Company has successfully completed its previously announced tender offer to acquire all outstanding shares of Kinnate Biopharma Inc. (NASDAQ: KN
EMERYVILLE, Calif., March 21, 2024 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA) (“XOMA” or the “Company”) today announced its Board of Directors has authorized the following cash dividends to holders of XOMA’s Series A and Series B Cumulative Preferred Stock: Holders of the 8.625% Series A Cumulative Perpetual Preferred Stock (Nasdaq: XOMAP) shall receive a cash dividend equal to $0.53906 per share. Holders of depositary shares, each representing 1/1000 of a share of XOMA’s 8.375% Series